High expression of HOXC6 predicts a poor prognosis and induces proliferation and inflammation in multiple myeloma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High expression of HOXC6 predicts a poor prognosis and induces proliferation and inflammation in multiple myeloma cells

Published:2023-05-18 Issue:7 Volume:45 Page:945-955
ISSN:1976-9571
Container-title:Genes & Genomics
language:en
Short-container-title:Genes Genom

Author:

Li Zhihua,Wang Yaru,Hou Xiaoxu,Guo Luyao,Li Yanling,Ma Yanping,Ma Yanping

Funder

Key R&D projects in Shanxi Province

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s13258-023-01397-3.pdf

Reference40 articles.

1. Bao H, Lu P, Li Y, Wang L, Li H, He D, Yang Y, Zhao Y, Yang L, Wang M et al (2011) Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack. Cancer Biol Ther 11:58–67

2. Bębnowska D, Hrynkiewicz R (2021) Immunological Prognostic Factors in Multiple Myeloma. 22

3. Börset M, Waage A, Brekke OL, Helseth E (1994) TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. Eur J Haematol 53:31–37

4. Demchenko YN, Glebov OK, Zingone A, Keats JJ, Bergsagel PL, Kuehl WM (2010) Classical and/or alternative NF-kappaB pathway activation in multiple myeloma. Blood 115:3541–3552

5. Diamond B, Maclachlan K, Chung DJ, Lesokhin AM, Ola Landgren C (2020) Maintenance therapy and need for cessation studies in multiple myeloma: focus on the future. Best Pract Res Clin Haematol 33:101140

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms;Molecular and Cellular Biochemistry;2024-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3